The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica
- PMID: 8052511
- DOI: 10.1017/s0031182000077428
The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica
Abstract
The effects of the novel benzimidazole, triclabendazole (TCBZ) ('Fasinex', Ciba-Geigy), in its active sulphoxide metabolite form (TCBZ-SX), on the tegumental ultrastructure of Fasciola hepatica were determined in vitro by transmission electron microscopy (TEM), using both intact flukes and tissue-slice material. At a concentration of 15 micrograms/ml, the tegument of the whole adult fluke showed ultrastructural changes only after prolonged time-periods, with vacuolation at the base of the syncytium and accumulation of T2 secretory bodies in the tegumental cells. At a concentration of 50 micrograms/ml, with both whole flukes and tissue-slices, the tegument appeared extremely abnormal with accumulation of secretory bodies towards the base of the syncytium. With longer incubation times, the tegument was completely sloughed away and the tegumental cells became synthetically inactive. The tegument of the 3-week-old juvenile became progressively convoluted at the apex, while in the basal regions there was severe vacuolation. In the tegumental cells, there were accumulations of T1 secretory bodies. These results confirm TCBZ as a potent fasciolicide, being very effective in disrupting the fluke tegument. They may go some way to explain the mode of action of this important fasciolicide.
Similar articles
-
Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).Parasitol Res. 1993;79(7):529-36. doi: 10.1007/BF00932235. Parasitol Res. 1993. PMID: 8278333
-
Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.Parasitology. 2006 Aug;133(Pt 2):195-208. doi: 10.1017/S0031182006000114. Epub 2006 May 2. Parasitology. 2006. PMID: 16650337
-
Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.Parasitol Res. 2007 Jan;100(2):365-77. doi: 10.1007/s00436-006-0270-4. Epub 2006 Oct 3. Parasitol Res. 2007. PMID: 17016729
-
Current Threat of Triclabendazole Resistance in Fasciola hepatica.Trends Parasitol. 2016 Jun;32(6):458-469. doi: 10.1016/j.pt.2016.03.002. Epub 2016 Apr 2. Trends Parasitol. 2016. PMID: 27049013 Review.
-
Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.Pathogens. 2015 Jun 26;4(3):431-56. doi: 10.3390/pathogens4030431. Pathogens. 2015. PMID: 26131614 Free PMC article. Review.
Cited by
-
Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals.Clin Transl Sci. 2023 Oct;16(10):1758-1767. doi: 10.1111/cts.13564. Epub 2023 Sep 8. Clin Transl Sci. 2023. PMID: 37688315 Free PMC article. Clinical Trial.
-
Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel.Iran J Parasitol. 2014 Apr-Jun;9(2):202-8. Iran J Parasitol. 2014. PMID: 25848386 Free PMC article.
-
Cassia alata L: potential role as anthelmintic agent against Hymenolepis diminuta.Parasitol Res. 2012 Sep;111(3):1187-92. doi: 10.1007/s00436-012-2950-6. Epub 2012 May 11. Parasitol Res. 2012. PMID: 22576858
-
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.Parasitol Res. 2004 Dec;94(6):427-38. doi: 10.1007/s00436-004-1222-5. Epub 2004 Oct 28. Parasitol Res. 2004. PMID: 15517388
-
The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.Parasitol Res. 2004 Feb;92(3):205-10. doi: 10.1007/s00436-003-1003-6. Epub 2003 Dec 3. Parasitol Res. 2004. PMID: 14652740
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous